Free tool
PBE and BIB: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between PBE and BIB
31% of their top holdings overlap by weight, with 9 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that BIB holds far more positions (267 vs 33), so it is broader beyond the top names.
| Holding | % of PBE | % of BIB |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 5.47% | 3.21% |
| Amgen Inc. | 5.22% | 4.48% |
| Vertex Pharmaceuticals Inc. | 4.99% | 4.65% |
| Biogen Inc. | 4.79% | 1.44% |
| Gilead Sciences, Inc. | 4.43% | 4.66% |
| United Therapeutics Corp. | 4.08% | 1.22% |
| Illumina, Inc. | 3.51% | 1.25% |
| Alnylam Pharmaceuticals, Inc. | 3.17% | 2.01% |
| Incyte Corp. | 3.06% | 0.97% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized